Indee Labs Status
The company received AUD 500,000 of grant funding from NSW State Government on August 8, 2018.
Developer of gene delivery hardware designed to unlock gene-modified cell therapy for the masses. The company's hardware is based on microfluidic technology that uses microfluidic vortex shedding to enable fast processing of small and large volumes of human primary immune cells and it can achieve high yield with a simple workflow and does not change human primary immune cell activation or exhaustion profiles, enabling efficient development and scalable manufacturing of gene-modified cell therapies.
Generating Revenue/Not Profitable
Privately Held (backing)
Venture Capital-Backed
Indee Labs Partners With Monomer Bio to Automate Engineered Immune Cell Culture! @indeelabs https://t.co/2bcLpf6fgJ
Are you attending @JPM in person or virtually? Schedule a meeting with the team @indeelabs to learn more our efforts on Hydropore for Research Use Only and Cell Therapy! https://t.co/domU8L9opx
Indee Labs Awarded $2M Contract to Scale up and out Hydropore for Cell Therapy https://t.co/np4JTzIgwE
The company received AUD 500,000 of grant funding from NSW State Government on August 8, 2018.
Indee Labs Partners With Monomer Bio to Automate Engineered Immune Cell Culture! @indeelabs https://t.co/2bcLpf6fgJ
Are you attending @JPM in person or virtually? Schedule a meeting with the team @indeelabs to learn more our efforts on Hydropore for Research Use Only and Cell Therapy! https://t.co/domU8L9opx
Indee Labs Awarded $2M Contract to Scale up and out Hydropore for Cell Therapy https://t.co/np4JTzIgwE
We are excited to introduce Hydropore™ for cell biology and cell therapy research, now available for Research Use Only! Check out our latest blog post to learn more! https://t.co/syvFPFGTsm
Check out our updated bioRxiv pre-print on CRISPR-Cas9 genome editing with µVS! Let us know what you think. #CRISPR #innovation #Biotechnology https://t.co/oQJdgJG9gO
Wrapping up a busy week at #JPM21! Download our free brochure to learn more about our non-viral gene delivery technology, competitive data, and Early Access program. #immunotherapy #CellTherapy https://t.co/K8B2KizELB
Indee Labs Announces Successful Early Access Program Launch #CellTherapy #CancerResearch #Innovation #JPM21 https://t.co/f8Mq7ARruC
https://t.co/LCzn1pbPZ7
thank you @Synthego and @minu_pr. Great work by @JustinAJarrell! https://t.co/tH9E1CpGNx
Indee Labs Awarded Grant from the National Institute of Allergy and Infectious Diseases https://t.co/UxjbXpEExx
good fun with @synthego https://t.co/TvQxuRzQKG
thank you for the post @synthego https://t.co/LME8otTEkI
check out our new website! https://t.co/oFjZdZLnk3
check out our new bioRxiv preprint! https://t.co/fe5OOz7pFS
Indee Labs Issued United States and International Patents for Intracellular Delivery System https://t.co/AbdFCOka10
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.
Add a review